Charles B O'keeffe - Net Worth and Insider Trading
Charles B O'keeffe Net Worth
The estimated net worth of Charles B O'keeffe is at least $13 Million dollars as of 2024-11-13. Charles B O'keeffe is the Director of Catalyst Pharmaceuticals Inc and owns about 565,057 shares of Catalyst Pharmaceuticals Inc (CPRX) stock worth over $13 Million. Details can be seen in Charles B O'keeffe's Latest Holdings Summary section.
Disclaimer: The insider information is derived from SEC filings. The estimated net worth is based on the final shares held after open market or private purchases and sales of common stock with a transaction code of "P" or "S" on Form 4, assuming that Charles B O'keeffe has not made any transactions after 2022-11-15 and currently still holds the listed stock(s). Please note that this estimate may not reflect the actual net worth.
Transaction Summary of Charles B O'keeffe
Charles B O'keeffe Insider Ownership Reports
Based on ownership reports from SEC filings, as the reporting owner, Charles B O'keeffe owns 1 companies in total, including Catalyst Pharmaceuticals Inc (CPRX) .
Click here to see the complete history of Charles B O'keeffe’s form 4 insider trades.
Insider Ownership Summary of Charles B O'keeffe
| Ticker | Comapny | Transaction Date | Type of Owner |
|---|---|---|---|
| CPRX | Catalyst Pharmaceuticals Inc | 2022-11-15 | director |
Charles B O'keeffe Latest Holdings Summary
Charles B O'keeffe currently owns a total of 1 stock. Charles B O'keeffe owns 565,057 shares of Catalyst Pharmaceuticals Inc (CPRX) as of November 15, 2022, with a value of $13 Million.
Latest Holdings of Charles B O'keeffe
| Ticker | Comapny | Latest Transaction Date | Shares Owned | Current Price ($) | Current Value ($) |
|---|---|---|---|---|---|
| CPRX | Catalyst Pharmaceuticals Inc | 2022-11-15 | 565,057 | 23.04 | 13,018,913 |
Holding Weightings of Charles B O'keeffe
Charles B O'keeffe Form 4 Trading Tracker
According to the SEC Form 4 filings, Charles B O'keeffe has made a total of 2 transactions in Catalyst Pharmaceuticals Inc (CPRX) over the past 5 years, including 1 buys and 1 sells. The most-recent trade in Catalyst Pharmaceuticals Inc is the sale of 87,985 shares on November 15, 2022, which brought Charles B O'keeffe around $1 Million.
Insider Trading History of Charles B O'keeffe
- 1
Charles B O'keeffe Trading Performance
GuruFocus tracks the stock performance after each of Charles B O'keeffe's buying transactions within different timeframes. To be detailed, the average return of stocks after 3 months bought by Charles B O'keeffe is 21.11%. GuruFocus also compares Charles B O'keeffe's trading performance to market benchmark return within the same time period. The performance of stocks bought by Charles B O'keeffe within 3 months outperforms 15 times out of 25 transactions in total compared to the return of S&P 500 within the same period.
You can select different timeframes to see how Charles B O'keeffe's insider trading performs compared to the benchmark.
Performance of Charles B O'keeffe
Average Return
Outperforming Transactions
| 1 Month | 3 Months | 6 Months | 1 Year | 2 Years | 3 Years | |
|---|---|---|---|---|---|---|
| Return(%) | 8.63 | | | | | |
| Relative Return to S&P 500(%) | 7.76 | | | | | |
Charles B O'keeffe Ownership Network
Ownership Network List of Charles B O'keeffe
Ownership Network Relation of Charles B O'keeffe
Charles B O'keeffe Owned Company Details
What does Catalyst Pharmaceuticals Inc do?
Who are the key executives at Catalyst Pharmaceuticals Inc?
Charles B O'keeffe is the director of Catalyst Pharmaceuticals Inc. Other key executives at Catalyst Pharmaceuticals Inc include VP Development & Management Steve Miller , Chief Commercial Officer Carmen Jeffrey Del , and Chief Medical Officer Gary Ingenito .
Catalyst Pharmaceuticals Inc (CPRX) Insider Trades Summary
Over the past 18 months, Charles B O'keeffe made no insider transaction in Catalyst Pharmaceuticals Inc (CPRX). Other recent insider transactions involving Catalyst Pharmaceuticals Inc (CPRX) include a net sale of 230,000 shares made by Gary Ingenito , a net sale of 90,000 shares made by David S Tierney , and a net sale of 190,000 shares made by Steve Miller .
In summary, during the past 3 months, insiders sold 165,000 shares of Catalyst Pharmaceuticals Inc (CPRX) in total and bought 0 shares, with a net sale of 165,000 shares. During the past 18 months, 741,406 shares of Catalyst Pharmaceuticals Inc (CPRX) were sold and 0 shares were bought by its insiders, resulting in a net sale of 741,406 shares.
Catalyst Pharmaceuticals Inc (CPRX)'s detailed insider trading history can be found in Insider Trading Tracker table.
Catalyst Pharmaceuticals Inc Insider Transactions
Charles B O'keeffe Mailing Address
Above is the net worth, insider trading, and ownership report for Charles B O'keeffe. You might contact Charles B O'keeffe via mailing address: 220 Miracle Mile, Suite 234, Coral Gables Fl 33134.
We'd love to learn more about your experiences on GuruFocus.com and how we can improve!
Take Survey
